Condition: Breast Cancer · Pancreas Cancer · Colon Cancer · Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\*. It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vegetables, fruit and fibre, and limiting ultra-processed foods, red meat, processed meats, sugary drinks and alcohol). It assesses the impact of a digital intervention (based on the use of the Open Food Facts app) as a complement to the nutritional education provided by the Interception program.
This description comes directly from the study's public registry record.
Bruno Raynard, MD · +33 (0) 1 42 11 42 11 · bruno.raynard@gustaveroussy.fr
Adeline Salasc, Pharm D · +33 (0) 1 42 11 42 11 · adeline.salasc@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| Institut Sainte Catherine | Avignon, France | Not Yet Recruiting |
| Eugène Marquis | Rennes, France | Recruiting |
| Gustave Roussy | Villejuif, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07436312